Travere Therapeutics (TVTX) Financials: Revenue & Earnings
TVTX$50.27-0.61 -1.20%
$4.74B
Market Cap
-111.29
P/E
16.28
Forward P/E
54
Score
Travere Therapeutics (TVTX) Financials: Revenue & Earnings
TVTX price $50.27 -0.61 -1.20%
- Ticker
- TVTX
- Price
- $50.27
- Change
- -0.61 -1.20%
- Market cap ?
- $4.74B
- P/E ?
- -111.29
- Forward P/E ?
- 16.28
- Dividend yield ?
- 0.00%
- Beta ?
- 1.14
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 54
- Value
- 26
- Quality
- 41
- Growth
- 96
Stocklytics score rationale: value 26, quality 41, growth 96.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 133591000 | 154937000 | 164246000 | 175338000 | 198321000 | 131836000 | 109460000 | 145238000 | 233175000 | 490728000 |
Travere Therapeutics, Inc. is a biopharmaceutical company developing therapies for rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral, once-daily, non-immunosuppressive medication targeting two pathways of disease progression (endothelin-1 and angiotensin-II). Sparsentan received accelerated FDA approval in February 2023 and full approval in September 2024 to slow kidney function…
Fair value
TVTX fair value $73.86. Price $50.27. Price is 32% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 118.66M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.58% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 94.26M. Net debt 235.70M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | -0.05 | — | 198.25M |
| 2026-08-04 | -0.37 | -0.13 | 169.58M | 157.27M |
| 2026-05-04 | -0.39 | -0.30 | 127.20M | 136.23M |
| 2026-02-19 | 0.03 | 0.03 | 129.69M | 144.55M |
| 2025-10-30 | 0.28 | -0.31 | 164.86M | 146.98M |
| 2025-08-06 | -0.14 | -0.28 | 114.45M | 99.55M |
| 2025-05-01 | -0.47 | -0.55 | 81.73M | 88.80M |
| 2025-02-20 | -0.73 | -0.58 | 74.79M | 72.38M |
| 2024-10-31 | -0.70 | -0.70 | 62.90M | 71.44M |
| 2024-08-01 | -0.90 | -0.87 | 54.12M | 57.77M |
| 2024-05-06 | -1.76 | -0.98 | 41.37M | 42.85M |
| 2024-02-15 | -1.16 | -1.27 | 45.06M | 41.51M |
| 2023-11-07 | -1.17 | -1.09 | 37.09M | 117.31M |
| 2023-08-03 | -1.13 | -1.16 | 59.70M | 53.71M |
| 2023-05-04 | -1.27 | -1.18 | 56.99M | 50.61M |
| 2023-02-23 | -1.03 | -1.04 | 55.87M | 53.01M |
| 2022-10-27 | -1.09 | -0.97 | 53.50M | 54.12M |
| 2022-08-04 | -1.05 | -0.94 | 54.17M | 49.63M |
| 2022-05-05 | -1.20 | -0.85 | 48.49M | 52.19M |
| 2022-02-24 | -0.84 | -0.72 | 57.25M | 57.80M |
| 2021-10-28 | -0.59 | -0.72 | 68.22M | 52.64M |
| 2021-07-29 | -0.64 | -0.73 | 54.62M | 54.62M |
| 2021-05-06 | -0.96 | -0.56 | 47.41M | 36.10M |
| 2021-03-01 | -2.37 | -0.43 | 50.98M | — |
| 2020-11-05 | -0.44 | -0.52 | 51.14M | — |
| 2020-07-30 | -0.58 | -0.56 | 48.43M | — |
| 2020-05-11 | 0.02 | -0.67 | 47.77M | — |
| 2020-02-24 | -0.70 | -0.64 | 46.69M | — |
| 2019-10-30 | -0.55 | -1.05 | 44.37M | — |
| 2019-08-06 | -0.92 | -0.64 | 44.71M | — |
| 2019-05-07 | -0.81 | -0.57 | 39.57M | — |
| 2019-02-26 | -0.18 | -0.48 | 43.77M | — |
| 2018-11-01 | -0.92 | -0.45 | 40.71M | — |
| 2018-07-26 | -0.56 | -0.35 | 41.34M | — |
| 2018-05-01 | -0.46 | -0.45 | 38.43M | — |
| 2018-02-27 | -0.45 | -0.19 | 42.18M | — |
| 2017-11-07 | -0.46 | -0.25 | 40.34M | — |
| 2017-08-09 | -0.34 | -0.21 | 38.80M | — |
| 2017-05-04 | -0.29 | -0.26 | 33.62M | — |
| 2017-03-01 | -0.23 | -0.26 | 37.33M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-15 | Dube Eric M | Buy | 200.00K | $8.93 | 1.79M |
| 2026-10-15 | Dube Eric M | Sell | 128.06K | $52.97 | 6.78M |
| 2026-10-15 | Dube Eric M | Sell | 37.27K | $54.20 | 2.02M |
| 2026-10-15 | Dube Eric M | Buy | 43.73K | $26.88 | 1.18M |
| 2026-10-15 | Dube Eric M | Sell | 78.40K | $55.02 | 4.31M |
| 2026-10-15 | Dube Eric M | Sell | 43.73K | $26.88 | 1.18M |
| 2026-10-15 | Dube Eric M | Sell | 200.00K | $8.93 | 1.79M |
| 2026-09-17 | Heerma Peter | Buy | 8.28K | $22.40 | 185.52K |
| 2026-09-17 | Heerma Peter | Sell | 8.28K | $65.07 | 538.92K |
| 2026-09-17 | Heerma Peter | Sell | 8.28K | $22.40 | 185.52K |
| 2026-09-17 | Dube Eric M | Buy | 108.49K | $23.34 | 2.53M |
| 2026-09-17 | Dube Eric M | Sell | 101.69K | $64.59 | 6.57M |
| 2026-09-17 | Dube Eric M | Sell | 6.80K | $64.95 | 441.80K |
| 2026-09-17 | Dube Eric M | Sell | 108.49K | $23.34 | 2.53M |
| 2026-09-16 | ROTE WILLIAM E. | Buy | 57.50K | $26.88 | 1.55M |
| 2026-09-16 | ROTE WILLIAM E. | Buy | 55.00K | $15.46 | 850.30K |
| 2026-09-16 | ROTE WILLIAM E. | Sell | 65.10K | $63.12 | 4.11M |
| 2026-09-16 | ROTE WILLIAM E. | Buy | 350 | $17.96 | 6.29K |
| 2026-09-16 | ROTE WILLIAM E. | Sell | 47.75K | $63.61 | 3.04M |
| 2026-09-16 | ROTE WILLIAM E. | Sell | 57.50K | $26.88 | 1.55M |
| 2026-09-16 | ROTE WILLIAM E. | Sell | 55.00K | $15.46 | 850.30K |
| 2026-09-16 | ROTE WILLIAM E. | Sell | 350 | $17.96 | 6.29K |
| 2026-09-16 | Heerma Peter | Buy | 17.72K | $26.88 | 476.23K |
| 2026-09-16 | Heerma Peter | Buy | 55.00K | $15.46 | 850.30K |
| 2026-09-16 | Heerma Peter | Buy | 100.00K | $11.25 | 1.12M |
| 2026-09-16 | Heerma Peter | Sell | 93.60K | $63.25 | 5.92M |
| 2026-09-16 | Heerma Peter | Sell | 79.11K | $63.65 | 5.04M |
| 2026-09-16 | Heerma Peter | Sell | 17.72K | $26.88 | 476.23K |
| 2026-09-16 | Heerma Peter | Sell | 100.00K | $11.25 | 1.12M |
| 2026-09-16 | Heerma Peter | Sell | 55.00K | $15.46 | 850.30K |
| 2026-09-16 | Dube Eric M | Buy | 195.84K | $23.34 | 4.57M |
| 2026-09-16 | Dube Eric M | Sell | 99.72K | $63.26 | 6.31M |
| 2026-09-16 | Dube Eric M | Sell | 96.12K | $63.64 | 6.12M |
| 2026-09-16 | Dube Eric M | Sell | 195.84K | $23.34 | 4.57M |
| 2026-09-15 | ROTE WILLIAM E. | Buy | 39.65K | $17.96 | 712.11K |
| 2026-09-15 | ROTE WILLIAM E. | Buy | 39.00K | $25.25 | 984.75K |
| 2026-09-15 | ROTE WILLIAM E. | Sell | 63.91K | $61.99 | 3.96M |
| 2026-09-15 | ROTE WILLIAM E. | Sell | 29.02K | $62.66 | 1.82M |
| 2026-09-15 | ROTE WILLIAM E. | Sell | 3.00K | $63.65 | 190.95K |
| 2026-09-15 | ROTE WILLIAM E. | Sell | 270 | $65.31 | 17.63K |
| 2026-09-15 | ROTE WILLIAM E. | Sell | 39.65K | $17.96 | 712.11K |
| 2026-09-15 | ROTE WILLIAM E. | Sell | 39.00K | $25.25 | 984.75K |
| 2026-09-15 | Heerma Peter | Buy | 36.53K | $8.93 | 326.18K |
| 2026-09-15 | Heerma Peter | Buy | 1.38K | $22.40 | 30.93K |
| 2026-09-15 | Heerma Peter | Buy | 39.28K | $26.88 | 1.06M |
| 2026-09-15 | Heerma Peter | Sell | 71.94K | $62.05 | 4.46M |
| 2026-09-15 | Heerma Peter | Sell | 27.42K | $62.59 | 1.72M |
| 2026-09-15 | Heerma Peter | Sell | 1.40K | $63.65 | 89.11K |
| 2026-09-15 | Heerma Peter | Sell | 1.43K | $65.31 | 93.46K |
| 2026-09-15 | Heerma Peter | Sell | 1.38K | $22.40 | 30.93K |
| 2026-09-15 | Heerma Peter | Sell | 36.53K | $8.93 | 326.18K |
| 2026-09-15 | Heerma Peter | Sell | 39.28K | $26.88 | 1.06M |
| 2026-09-15 | Inrig Jula | Buy | 32.40K | $8.93 | 289.29K |
| 2026-09-15 | Inrig Jula | Sell | 25.39K | $62.02 | 1.57M |
| 2026-09-15 | Inrig Jula | Sell | 17.28K | $62.62 | 1.08M |
| 2026-09-15 | Inrig Jula | Sell | 1.60K | $63.69 | 101.90K |
| 2026-09-15 | Inrig Jula | Sell | 400 | $65.31 | 26.12K |
| 2026-09-15 | Inrig Jula | Sell | 32.40K | $8.93 | 289.29K |
| 2026-09-15 | REED ELIZABETH E | Buy | 37.50K | $15.46 | 579.75K |
| 2026-09-15 | REED ELIZABETH E | Sell | 21.93K | $62.03 | 1.36M |
| 2026-09-15 | REED ELIZABETH E | Sell | 13.87K | $62.63 | 868.96K |
| 2026-09-15 | REED ELIZABETH E | Sell | 1.40K | $63.69 | 89.17K |
| 2026-09-15 | REED ELIZABETH E | Sell | 300 | $65.31 | 19.59K |
| 2026-09-15 | REED ELIZABETH E | Sell | 37.50K | $15.46 | 579.75K |
| 2026-09-15 | Dube Eric M | Buy | 95.67K | $23.34 | 2.23M |
| 2026-09-15 | Dube Eric M | Sell | 63.50K | $61.99 | 3.94M |
| 2026-09-15 | Dube Eric M | Sell | 28.80K | $62.66 | 1.80M |
| 2026-09-15 | Dube Eric M | Sell | 3.10K | $63.64 | 197.42K |
| 2026-09-15 | Dube Eric M | Sell | 270 | $65.31 | 17.63K |
| 2026-09-15 | Dube Eric M | Sell | 95.67K | $23.34 | 2.23M |
| 2026-09-15 | Cline Christopher R. | Buy | 20.00K | $17.44 | 348.80K |
| 2026-09-15 | Cline Christopher R. | Sell | 27.47K | $62.00 | 1.70M |
| 2026-09-15 | Cline Christopher R. | Sell | 20.73K | $62.61 | 1.30M |
| 2026-09-15 | Cline Christopher R. | Sell | 1.90K | $63.69 | 121.00K |
| 2026-09-15 | Cline Christopher R. | Sell | 400 | $65.31 | 26.12K |
| 2026-09-15 | Cline Christopher R. | Sell | 20.00K | $17.44 | 348.80K |
| 2026-09-15 | Calvin Sandra | Buy | 1.62K | $20.46 | 33.25K |
| 2026-09-15 | Calvin Sandra | Buy | 1.25K | $22.40 | 28.00K |
| 2026-09-15 | Calvin Sandra | Buy | 2.50K | $27.50 | 68.75K |
| 2026-09-15 | Calvin Sandra | Sell | 4.28K | $62.13 | 265.63K |
| 2026-09-15 | Calvin Sandra | Sell | 800 | $62.85 | 50.28K |
| 2026-09-15 | Calvin Sandra | Sell | 300 | $63.66 | 19.10K |
| 2026-09-15 | Calvin Sandra | Sell | 1.62K | $20.46 | 33.25K |
| 2026-09-15 | Calvin Sandra | Sell | 1.25K | $22.40 | 28.00K |
| 2026-09-15 | Calvin Sandra | Sell | 2.50K | $27.50 | 68.75K |
| 2026-09-10 | Meckler Jeffrey A | Buy | 10.00K | $26.52 | 265.20K |
| 2026-09-10 | Meckler Jeffrey A | Sell | 1.70K | $65.39 | 111.17K |
| 2026-09-10 | Meckler Jeffrey A | Sell | 1.20K | $66.15 | 79.38K |
| 2026-09-10 | Meckler Jeffrey A | Buy | 10.00K | $17.44 | 174.40K |
| 2026-09-10 | Meckler Jeffrey A | Sell | 14.00K | $67.46 | 944.49K |
| 2026-09-10 | Meckler Jeffrey A | Sell | 3.10K | $68.09 | 211.07K |
| 2026-09-10 | Meckler Jeffrey A | Sell | 10.00K | $17.44 | 174.40K |
| 2026-09-10 | Meckler Jeffrey A | Sell | 10.00K | $26.52 | 265.20K |
| 2026-09-02 | Cline Christopher R. | Sell | 642 | $66.37 | 42.61K |
| 2026-08-18 | LYONS GARY A | Buy | 5.00K | $17.44 | 87.20K |
| 2026-08-18 | LYONS GARY A | Sell | 4.10K | $63.27 | 259.39K |
| 2026-08-18 | LYONS GARY A | Sell | 900 | $63.86 | 57.47K |
| 2026-08-18 | LYONS GARY A | Sell | 5.00K | $17.44 | 87.20K |
| 2026-08-17 | LYONS GARY A | Sell | 1.90K | $62.53 | 118.80K |
| 2026-08-17 | LYONS GARY A | Sell | 2.60K | $63.50 | 165.10K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 332, holders +52 vs prior quarter. Ownership 113.51%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| JUPITER TOPCO LLC | 11.32M | 11.32M | New | 643.30M |
| BLACKROCK, INC. | 8.02M | 228.63K | +2.93% | 455.65M |
| FMR LLC | 7.10M | -3.87M | -35.30% | 403.16M |
| BANK OF AMERICA CORP /DE/ | 4.57M | 3.22M | +239.63% | 259.53M |
| STATE STREET CORP | 4.26M | -703.76K | -14.19% | 241.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.11M | 62.88K | +1.55% | 233.41M |
| PERCEPTIVE ADVISORS LLC | 3.75M | -389.98K | -9.41% | 213.18M |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.81M | -458.00K | -14.00% | 159.78M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.57M | 1.59M | +162.98% | 145.97M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.37M | 2.33K | +0.10% | 134.77M |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.18M | 701.12K | +47.44% | 123.79M |
| KYNAM CAPITAL MANAGEMENT, LP | 2.00M | 1.20M | +150.00% | 113.62M |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 1.88M | 76.84K | +4.27% | 106.54M |
| RENAISSANCE TECHNOLOGIES LLC | 1.83M | -133.70K | -6.80% | 104.14M |
| EMERALD ADVISERS, LLC | 1.60M | 43.69K | +2.81% | 90.95M |
| ARMISTICE CAPITAL, LLC | 1.57M | -3.32M | -67.89% | 89.34M |
| TWO SIGMA INVESTMENTS, LP | 1.57M | 57.40K | +3.81% | 88.94M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.54M | -167.52K | -9.80% | 87.58M |
| GOLDMAN SACHS GROUP INC | 1.54M | -184.40K | -10.72% | 87.22M |
| WELLINGTON MANAGEMENT GROUP LLP | 1.53M | 510.81K | +49.97% | 87.09M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 1.44M | 774.07K | +115.68% | 81.99M |
| D. E. SHAW & CO., INC. | 1.44M | 603.92K | +72.19% | 81.83M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.44M | 156.62K | +12.21% | 81.76M |
| MARSHALL WACE, LLP | 1.33M | 1.15M | +646.74% | 75.74M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.32M | 913.81K | +225.74% | 74.91M |
Earnings and financials
Travere Therapeutics, Inc. (TVTX) trades at $50.27, with a market cap of $4.74B and a trailing P/E of -111.29. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 133591000 | 154937000 | 164246000 | 175338000 | 198321000 | 131836000 | 109460000 | 145238000 | 233175000 | 490728000 |
Insights · Dividends · Forecast · Financials · Learn